BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Robinson A, Ohri A, Liu B, Bhuket T, Wong RJ. One in five hepatocellular carcinoma patients in the United States are Hispanic while less than 40% were eligible for liver transplantation. World J Hepatol 2018; 10(12): 956-965 [PMID: 30631400 DOI: 10.4254/wjh.v10.i12.956]
URL: https://www.wjgnet.com/1948-5182/full/v10/i12/956.htm
Number Citing Articles
1
Boris J. B. Beudeker, Andre Boonstra. Circulating biomarkers for early detection of hepatocellular carcinomaTherapeutic Advances in Gastroenterology 2020; 13: 175628482093173 doi: 10.1177/1756284820931734
2
Sydney Pomenti, Cassandra Gandle, Hamzah Abu Sbeih, Meaghan Phipps, Alexandra Livanos, Averill Guo, Jonathan Yeh, Heather Burney, Hao Liu, Lara Dakhoul, Carla Kettler, Samer Gawrieh, Andrew deLemos, Andrew Scanga, Naga Chalasani, Ethan Miller, Julia Wattacheril. Hepatocellular Carcinoma in Hispanic Patients: Trends and Outcomes in a Large United States CohortHepatology Communications 2020; 4(11): 1708 doi: 10.1002/hep4.1575
3
Yedidya Saiman, Royce Hooks, Rotonya M. Carr. High-Risk Groups for Non-alcoholic Fatty Liver and Non-alcoholic Steatohepatitis Development and ProgressionCurrent Hepatology Reports 2020; 19(4): 412 doi: 10.1007/s11901-020-00539-5